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ABSTRACT
Staphylococcus aureus has become a frequent coloniser of the intestinal tract of infants, but the health
effects of such colonisation are not clear. In this study, the antibiotic resistance patterns of 116 S. aureus
strains from the commensal intestinal microflora were determined. The strains were obtained from 81
Swedish infants who had been followed with regular stool samples and registration of antibiotic usage
during their first year of life. The faecal population levels of the individual strains and the duration of
their persistence in the microflora had been determined previously. The prevalence of antibiotic
resistance among the 116 strains was modest: methicillin, 0%; penicillin G, 78%; erythromycin A, 3%;
tetracycline, 2%; clindamycin, 0.9%; and fusidic acid, 0.9%. Colonisation by antibiotic-resistant strains
was unrelated to antibiotic consumption by individual infants. Antibiotic-resistant strains were as
capable of persisting in the intestinal microflora and reaching high faecal population levels as fully
susceptible strains. No strain lost or acquired resistance during the colonisation period. Thus, antibiotic-
resistant strains of S. aureus seem to be as fit for competition in the large bowel microflora as susceptible
strains, even in the absence of selective pressure from antibiotics. This may aggravate the ecological
consequences of antibiotic resistance development.
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INTRODUCTION
Staphylococcus aureus is a common cause of sep-
ticaemia and soft tissue infections, but is also a
member of the normal skin flora. In addition,
S. aureus frequently colonises the intestinal tract of
Swedish infants, often persisting for several
months in the intestinal microflora of individual
infants, seemingly without untoward effects on
their health [1].
Staphylococci are inherently susceptible to most
antibiotics, except those with a purely Gram-
negative spectrum. However, b-lactamase produc-
tion evolved rapidly in S. aureus, and > 50% of
hospital-acquired S. aureus isolates were penicillin
G-resistant by 1948, with this proportion now
reaching 80–90% [2]. As new antibiotics were
introduced to the market, e.g., tetracycline, strep-
tomycin, erythromycin and gentamicin, S. aureus
isolates resistant to these antibiotics appeared.
Methicillin, a penicillin resistant to S. aureus
b-lactamase, was introduced into clinical practice
in 1960 [2], but the first resistant strain was iden-
tified 1 year later. Methicillin-resistant S. aureus
strains have spread with unanticipated speed in
many countries [3]. In 2003, two clinical S. aureus
isolates were identified that carried the vanA gene
conferring resistance to vancomycin [4–6].
The normal microflora colonising the skin and
mucous membranes may be an important reser-
voir for antibiotic-resistant bacterial strains, and
transfer of resistance elements may also occur in
these complex microbial communities. For exam-
ple, methicillin-resistant S. aureus may arise
de novo in community strains through horizontal
acquisition of the mecA gene [7]. Despite this, the
ecological role of antibiotic resistance and the risk
of transfer of resistance elements between strains
in the normal microflora have rarely been studied.
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In the present study, intestinal S. aureus strains
from 81 Swedish infants were tested for resistance
to a range of commonly used antibiotics. Stool
samples from these infants had been obtained
regularly over the first year of life and cultured
quantitatively for S. aureus in a study examining
the role of infant intestinal colonisation pattern on
allergy development [1,8]. As all medical treat-
ments had been registered, colonisation by resist-
ant strains could be correlated with antibiotic
consumption. Furthermore, all S. aureus isolates
from each individual infant had been character-
ised by random amplified polymorphic DNA
analysis to determine their strain identity. Persist-
ence in the microflora and faecal population
numbers of each strain had been determined and
could be compared between resistant and sus-
ceptible S. aureus strains. Thus, the effect of
antibiotic resistance on the fitness of S. aureus in
the colonic microflora could be assessed.
MATERIALS AND METHODS
Infants and S. aureus isolates
In total, 116 S. aureus strains were obtained from 81 healthy
Swedish infants born between 1998 and 2002 at the Sahlgrenska
University Hospital (n = 78) or Varberg Hospital (n = 3) in
south-west Sweden. These infants were in a cohort of 120
infants who harboured S. aureus in their intestinal microflora at
least once during their first year of life. The cohort was
recruited for a previous study [1,8], and the S. aureus coloni-
sation pattern of the cohort has been described previously [1].
The sampling schedule consisted of rectal swab cultures taken
at an age of 3 days, and quantitative cultures of infants’ stools
at the ages of 1, 2, 4 and 8 weeks, and 6 and 12 months. S. aureus
was isolated and identified to the strain level as described
previously [1].
One or more toxins was produced by 36% of the strains, as
determined by reversed passive latex agglutination (Oxoid,
Basingstoke, UK). Staphylococcal enterotoxins A, B, C and D
were produced by 12, 2, 23 and 2 strains, respectively. Toxic
shock syndrome toxin 1 was produced by 17 strains.
The infants’ feeding patterns, health status and antibiotic
consumption were registered by the parents in a diary, and
these details were recorded after 6 and 12 months by a study
nurse via a telephone interview. Informed consent was
obtained from the parents, and the study was approved by
the Medical Ethics Committee of Go¨teborg University.
Antibiotic susceptibility testing
Antibiotic susceptibility was tested by the agar disk diffusion
method [9]. S. aureus isolates were cultivated overnight on blood
agar plates. Five to ten colonies were picked with a sterile loop
and suspended in 2 mL of phosphate-buffered saline to a
density of 0.5· McFarland standard. This was further diluted
1:100 and spread on PDM antibiotic sensitivity testing medium
agar plates using a cotton-tipped swab (AB Biodisk, Solna,
Sweden). The following antibiotic-containing disks were
applied: penicillin G (10 lg), vancomycin (5 lg), teicoplanin
(30 lg), erythromycin A (15 lg), tetracycline (30 lg), clindamy-
cin (15 lg), gentamicin (30 lg), tobramycin (30 lg), ciprofloxa-
cin (10 lg), trimethoprim (5 lg), fusidic acid (50 lg), and
chloramphenicol (30 lg) (AB Biodisk). After the plates had been
incubated at 37C for 16–20 h, the zone diameters were meas-
ured and the isolates were defined as sensitive, intermediate or
resistant [9]. For methicillin, a bacterial suspension correspond-
ing to 0.5· MacFarland standard was inoculated on to PDM
blood agar plates, and an oxacillin disk (1 lg) was applied. Zone
diameters were measured after incubation at 30C for 24 h.
Isolates with penicillin G zones of > 30 mm were tested for
b-lactamase production using the nitrocefin test (Oxoid); isolates
producing b-lactamase were defined as penicillin-resistant.
MICs were determined by Etest [10] for isolates that were not
fully susceptible to erythromycin A, tetracycline or clindamycin
by the disk diffusion method. Etest strips (AB Biodisk) were
placed on PDM agar plates inoculated with a bacterial suspen-
sion (0.5· McFarland standard) and incubated for 20 h at 37C.
PCR experiments
All isolates were tested for presence of the mecA gene with the
primer set MecA1 (5¢-GTAGAAATGATCGAACGTCCGAT-
AA-3¢) and MecA3 (5¢-CCAATTCCACATTGTTTCGGTCTAA-
3¢) (Scandinavian Gene Synthesis, Ko¨ping, Sweden) [11].
Bacterial DNA was released using the modified InstaGene
protocol (Bio-Rad, Richmond, CA, USA). PCR reactions con-
tained 4 lL DNA, 10 pmol of each primer, 0.1 mmol dNTPs,
3.0 mmol MgCl2, and 2 U Taq polymerase. Thermal cycling
parameters comprised 4 min at 94C, followed by 30 cycles of
45 s at 94C, 45 s at 62C and 2 min at 72C. The 310-bp mecA
product was detected by electrophoresis on agarose 1.8% w ⁄v
gels, followed by ethidium bromide staining and examination
under UV light.
Erythromycin-resistant isolates were examined by PCR for
the presence of the methylase genes ermA, ermB, ermC and
ermTR and the efflux pump genes msrA and mefA ⁄E as
described previously [12].
RESULTS
Antibiotic resistance in S. aureus strains
The antibiotic resistance patterns of the 116
S. aureus strains are shown in Table 1; 78% of
the strains were resistant to penicillin. Five strains
were resistant to penicillin G and at least one
other antibiotic: erythromycin A and clindamycin
(one strain), erythromycin A and tetracycline
(one), erythromycin A (one), tetracycline (one)
and fusidic acid (one).
Strains defined as resistant to erythromycin A,
tetracycline or clindamycin by the disk diffusion
method exhibited MICs of these antibiotics that
exceeded those obtained when testing strains
lacking resistance mechanisms, as defined by the
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Swedish Reference Group for Antibiotics
(Table 1) [9].
There were no significant differences in antibi-
otic resistance between toxin-producing and non-
toxin-producing strains (Fisher’s exact test, data
not shown).
Antibiotic resistance and fitness in the
microflora
The population counts of each S. aureus strain had
been determined previously [1]. The average
population counts of strains fully susceptible to
all antibiotics (n = 25), resistant to penicillin G
only (n = 86), or resistant to penicillin G and at
least one other antibiotic (n = 5), were compared.
The stool counts of S. aureus decrease with age as a
more complex flora develops [1], but antibiotic-
resistant and -sensitive strains had similar average
population numbers at each time-point (Fig. 1).
Seventy-eight S. aureus strains persisted in the
intestinal microflora of an infant for an average of
17 weeks [1]. Several isolates of these strains were
available, and the antibiotic resistance patterns of
the first and last isolate were determined. If the
strain was resistant to any antibiotic in addition to
penicillin G (n = 5), the antibiotic resistance pat-
terns of all isolates were determined. In each case,
all tested isolates of a single strain showed
identical patterns of antibiotic resistance.
Strains that colonised an infant for ‡ 3 weeks
were defined as resident, while those colonising
for shorter periods were defined as transient [13].
In the present study, 78 strains were defined as
resident and 18 as transient, while strains that
occurred only at 2, 6 or 12 months could not be
classified because of the long sampling intervals.
Resistance to antibiotics (penicillin G only, or
penicillin G plus at least one other antibiotic) was
more common among resident than transient
strains, but the difference did not reach statistical
significance (p 0.09) (Table 2). All five strains that
were resistant to penicillin and at least one other
antibiotic were resident in the microflora.
Antibiotic consumption and resistance
Seventeen (21%) of the 81 infants had been
treated with antibiotics during their first year.
Six of these received more than one type of
antibiotic. Ten infants received penicillin V, nine
amoxycillin, two trimethoprim, and one infant
each erythromycin, penicillin G or fusidic acid.
Sixteen infants received b-lactam antibiotics,
and the resistance patterns of strains from these
Table 1. Frequency of resistance to antibiotics in 116









(mg/L)an % n %
Penicillin G 69 85 91 78 ND
Erythromycin A 3 4 3 3 256
Tetracycline 2 3 3 2 8–24
Clindamycin 1 1 1 0.9 256
Fusidic acid 1 1 1 0.9 ND
Oxacillin 0 0 0 0 –
Vancomycin 0 0 0 0 –
Teicoplanin 0 0 0 0 –
Gentamicin 0 0 0 0 –
Tobramycin 0 0 0 0 –
Ciprofloxacin 0 0 0 0 –
Trimethoprim 0 0 0 0 –
Chloramphenicol 0 0 0 0 –
ND, not determined.
















(Penicillin G + other) R
(Penicillin G only) R
Fully susceptible
Age
Fig. 1. Faecal population counts of Staphylococcus aureus
isolated from infant stools collected at different time-
points. The mean population counts at different infant ages
of strains resistant to penicillin G only, of strains resistant
to penicillin G and other antibiotics, and of fully sensitive
strains, are shown. Quantitative cultures were performed
from fresh stools on staphylococcus agar as described
previously [1].
Table 2. Frequency of resistance to penicillin G (PcG) or
other antibiotics in resident and transient intestinal Sta-




susceptible (%)Only PcG PcG + other
Resident strainsa 78 78 7 15
Transient strains 19 67 0 33
aStrains persisting in the microflora of an infant for > 3 weeks were termed resident;
strains persisting for shorter periods were termed transient.
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infants and strains from infants who did not
receive b-lactam antibiotics are shown in Table 3.
There was no difference in penicillin resistance
between these groups of strains (Table 3). One
infant received penicillin V between 6 and
12 months, and the same penicillin-sensitive
strain was isolated at both time-points. However,
it is unclear whether the strain persisted during
treatment, or whether the child was recolo-
nised with the same strain, e.g., from household
contacts.
Among the five strains that were resistant to
both penicillin G and at least one other antibiotic,
three were found in infants who did not receive
antibiotics. Two strains were found in infants who
received ampicillin, or tobramycin and trimetho-
prim, respectively, but the strains had been
established in the microflora before treatment.
Moreover, the resistance patterns of the strains
(erythromycin A and clindamycin, and erythro-
mycin A and tetracycline, respectively) were not
related to the antibiotics received.
Resistance genes
None of the 116 strains analysed was mecA-
positive. Of the three isolates that were resistant
to erythromycin, one was positive for the ermA
gene, and one for the ermC gene. The third isolate
was negative for all genes tested, but the resist-
ance phenotype was suggestive of erm gene
carriage.
DISCUSSION
S. aureus is both an important pathogen and a
common member of the commensal flora. In the
present study, commensal S. aureus strains isola-
ted from the intestinal flora of healthy Swedish
infants were assayed for susceptibility to a range
of commonly used antibiotics. S. aureus colonises
the intestines of 75% of Swedish infants during
the first year of life [1], and assessment of these
resistance patterns may give an insight into the
ecological consequences for S. aureus of antibiotic
treatment of individuals and antibiotic usage in
society at large.
The strains isolated were resistant to penicillin
G (78%), erythromycin (3%), tetracycline (2%),
clindamycin (0.9%) and fusidic acid (0.9%), but
not to methicillin. These figures were similar to or
slightly lower than those reported with clinical
S. aureus isolates in Sweden for erythromycin
(3.8%), clindamycin (1.9%), and methicillin
(0.7%) [9]. Resistance to fusidic acid was more
common among clinical isolates (9.5% in 2002),
which may relate to clonal spread in Sweden of
fusidic acid-resistant S. aureus causing superficial
infections [14]. These clinical isolates were from a
cross-selective sample from adults and children
throughout Sweden. To our knowledge, no com-
parisons have been made between S. aureus
isolates deriving from adults and children. How-
ever, as strains colonising infant intestines usually
derive from the parents’ skin flora [8], the S. aureus
tested in the present study may represent com-
mensal isolates from healthy people in a Swedish
urban population.
As antibiotic-resistant strains appeared in the
microflora without any obvious link to antibiotic
treatment of the individual infant, the antibiotic
policy of society at large may be more important
than the antibiotic consumption of the individual
in this context. Antibiotic consumption in Sweden
is lower than in the UK (13.5 vs. 18.0 daily
doses ⁄ 1000 inhabitants ⁄day) [15], and commensal
S. aureus strains isolated from healthy British
children by mouthwash were more resistant
compared to our findings: erythromycin (6%),
tetracycline and chloramphenicol (3% each), and
methicillin (2%) [16]. Similarly, 2.5% of S. aureus
isolates from the nares of healthy children in
Chicago, USA were methicillin-resistant [17].
The infants in the present study were followed
longitudinally with regular sampling of the
microflora. Consecutive isolates of persisting
strains were examined and all were found to
maintain their antibiotic susceptibility or resist-
ance patterns over the entire colonisation period.
Furthermore, resistant strains persisted in the
intestinal microflora for as long, and reached
similar population levels, as fully sensitive
Table 3. Frequency of penicillin-resistant strains in the









Non-b-lactam-treated children (n = 65a) 92 73 (79) 19 (21)
b-Lactam-treated children (n = 16b) 24
Strains found before b-lactam-treatment 16 12 (75) 4 (25)
Strains found after b-lactam-treatment 3 2 (67) 1 (33)
Strains found before and after treatment 5 4 (80) 1 (20)
aOne child was treated with erythromycin, and the others received no antibiotics.
bPenicillin V (ten children), amoxycillin (nine children), or penicillin G (one child).
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strains. Thus, resistance to antibiotics did not
seem to impede the survival fitness of S. aureus in
the intestinal commensal microflora. Strains that
have acquired resistance in one host may there-
fore spread to other hosts unhindered by their
resistance phenotype. This points to the need to
minimise the total antibiotic load in society.
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